CDC-Authored Genomics and Precision Health Publications Database
Last data update: Apr 22, 2024. (Total: 5878 publications)
Query Trace: Lyman M[original query] |
---|
Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates
Misas E , Seagle E , Jenkins EN , Rajeev M , Hurst S , Nunnally NS , Bentz ML , Lyman MM , Berkow E , Harrison LH , Schaffner W , Markus TM , Pierce R , Farley MM , Chow NA , Lockhart SR , Litvintseva AP . J Clin Microbiol 2024 e0114023 |
Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.
Khoury MJ , Feero WG , Chambers DA , Brody LC , Aziz N , Green RC , Janssens Acjw , Murray MF , Rodriguez LL , Rutter JL , Schully SD , Winn DM , Mensah GA . PLoS Med 2018 15 (8) e1002650 |
Investigation of a Candida auris outbreak in a Skilled Nursing Facility - Virginia, United States, October 2020-June 2021.
Waters A , Chommanard C , Baltozer S , Angel LC , Abdelfattah R , Lyman M , Forsberg K , Misas E , Litvintseva AP , Fields V , Lineberger S , Bernard S . Am J Infect Control 2022 51 (4) 472-474 |
Tools for detecting a "superbug": updates on Candida auris testing.
Lockhart SR , Lyman MM , Sexton DJ . J Clin Microbiol 2022 60 (5) jcm0080821 |
Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.
Paveenkittiporn W , Lyman M , Biedron C , Chea N , Bunthi C , Kolwaite A , Janejai N . Antimicrob Resist Infect Control 2021 10 (1) 88 |
Candida auris Whole-Genome Sequence Benchmark Dataset for Phylogenomic Pipelines
Welsh RM , Misas E , Forsberg K , Lyman M , Chow NA . J Fungi (Basel) 2021 7 (3) |
Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014.
Tressler SR , Del Rosario MC , Kirby MD , Simmons AN , Scott MA , Ibrahim S , Forbi JC , Thai H , Xia GL , Lyman M , Collier MG , Patel PR , Bixler D . Infect Control Hosp Epidemiol 2021 42 (12) 1-6 |
Evidence synthesis and guideline development in genomic medicine: current status and future prospects.
Schully SD , Lam TK , Dotson WD , Chang CQ , Aronson N , Birkeland ML , Brewster SJ , Boccia S , Buchanan AH , Calonge N , Calzone K , Djulbegovic B , Goddard KA , Klein RD , Klein TE , Lau J , Long R , Lyman GH , Morgan RL , Palmer CG , Relling MV , Rubinstein WS , Swen JJ , Terry SF , Williams MS , Khoury MJ . Genet Med 2014 17 (1) 63-7 |
Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.
Simonds NI , Khoury MJ , Schully SD , Armstrong K , Cohn WF , Fenstermacher DA , Ginsburg GS , Goddard KA , Knaus WA , Lyman GH , Ramsey SD , Xu J , Freedman AN . J Natl Cancer Inst 2013 105 (13) 929-36 |
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.
Goddard KA , Knaus WA , Whitlock E , Lyman GH , Feigelson HS , Schully SD , Ramsey S , Tunis S , Freedman AN , Khoury MJ , Veenstra DL . Genet Med 2012 14 (7) 633-42 |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: